allyl 3-hydroxybenzoate | 83281-53-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: allyl 3-hydroxybenzoate
• 英文别名: prop-2-enyl 3-hydroxybenzoate
• CAS: 83281-53-2
• 化学式: C₁₀H₁₀O₃
• mdl: MFCD24388373
• 分子量: 178.188
• InChiKey: XIDRVYBJEHWUDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  allyl 3-hydroxybenzoate 在 三乙烯二胺 、 戴斯-马丁氧化剂 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 3-[3-(4-Decyloxy-benzyloxy)-2-oxo-propoxy]-benzoic acid allyl ester
  参考文献：
  名称：

  Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A₂ Based on a 1,3-Disubstituted Propan-2-one Skeleton

  摘要：

  Using knowledge of the substrate specificity of cPLA(2) (phospliolipases A(2)), a novel series of inhibitors of this enzyme were designed based upon a three point model of inhibitor binding to the enzyme active site comprising a lipophilic anchor, an electrophilic serine "trap", and an acidic binding moiety. The resulting 1,3-diheteroatom-substituted propan-2-ones were evaluated as inhibitors of cPLA2 in both aggregated bilayer and soluble substrate assays. Systematic variation of the lipophilic, electrophilic, and acidic groups revealed a well-defined structure-activity relationship against the enzyme. Optimization of each group led to compound 22 (ARC70484XX), which contains a decyloxy lipophilic side chain, a 1,3-diaryloxypropan-2-one moiety as a unique serine trap, and a benzoic acid as the acidic binding group. AR-C70484XX was found to be among the most potent in vitro inhibitors of cPLA2, described to date being more than 20-fold more active against the isolated enzyme (IC50 = 0.03 muM) than the standard CPLA(2) inhibitor, arachidonyl trifluoromethyl ketone (AACOCF(3)), and also greater than 10-fold more active than AACOCF3 against the cellular production of arachidonic acid by HL60 cells (IC50 = 2.8 muM).

  DOI：

  10.1021/jm011050x
• 作为产物：
  描述：

  3-(chlorocarbonyl)phenyl acetate 在 三乙胺 、 N,N-二甲基-1,3-二氨基丙烷 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 allyl 3-hydroxybenzoate
  参考文献：
  名称：

  CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS

  摘要：

  具有结构限制的、空间定义的12-30环的大环系统Ia和Ib由三个不同的分子部分构成：模板A、构象调节剂B和桥C。这些大环Ia和Ib可以通过并行合成或溶液中或固相上的组合化学来轻松制备。它们被设计用于与各种特定的生物靶标类相互作用，例如对G蛋白偶联受体（GPCRs）、离子通道和信号转导途径的激动或拮抗活性。特别地，这些大环作为莫蒂林受体的拮抗剂、FP受体和嘌呤受体P2Y1的调节剂、5-HT2B亚型的5-羟色胺受体的调节剂、电压门控钾通道Kv1.3的阻断剂以及β-连环蛋白依赖的“经典”Wnt途径的抑制剂。因此，它们显示出作为各种疾病药物的巨大潜力。

  公开号：

  US20120270881A1

文献信息

• [Pd(μ-Br)(P^<i>t</i>Bu₃)]₂ as a Highly Active Isomerization Catalyst: Synthesis of Enol Esters from Allylic Esters
  作者：Patrizia Mamone、Matthias F. Grünberg、Andreas Fromm、Bilal A. Khan、Lukas J. Gooßen

  DOI：10.1021/ol301563g

  日期：2012.7.20

  to be highly active for catalyzing double-bond migration in various substrates such as unsaturated ethers, alcohols, amides, and arenes, under mild conditions. It efficiently mediates the conversion of allylic esters into enol esters, rather than inserting into the allylic C–O bond. The broad applicability of this reaction was demonstrated with the synthesis of 22 functionalized enol esters.

  发现二聚体Pd（I）络合物[Pd（μ-Br）（P t Bu 3）] 2具有高活性，可催化不饱和醚，醇，酰胺和芳烃等各种底物中的双键迁移，在温和的条件下。它有效地调节了烯丙基酯到烯醇酯的转化，而不是插入烯丙基C–O键。通过合成22种官能化的烯醇酯证明了该反应的广泛适用性。
• [EN] COMPOUNDS AND THERAPEUTIC USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS THÉRAPEUTIQUES
  申请人：CENTAURI THERAPEUTICS LTD

  公开号：WO2017060729A1

  公开（公告）日：2017-04-13

  The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.

  该发明涉及具有将免疫反应与特定治疗靶标联系起来的新化合物，以及将该类化合物用于治疗癌症、由感染性因子介导和/或引起的疾病或紊乱，包含该类化合物的组合物，其制备过程以及用于该过程的新中间体。
• Bi-aromatic compounds, compositions containing them and uses
  申请人：Centre International de Recherches Dermatologiques

  公开号：US06326510B1

  公开（公告）日：2001-12-04

  The invention relates to novel biaromatic compounds having general formula I and their use in pharmaceutical compositions for use in human and veterinary medicine, in particular for treating dermatological, rheumatic, respiratory, cardiovascular, and ophthalmological disorders, and for use in cosmetic compositions.

  该发明涉及具有一般式I的新型双芳香化合物及其在人类和兽医药物组合物中的应用，特别用于治疗皮肤病、风湿病、呼吸系统疾病、心血管疾病和眼科疾病，并用于化妆品组合物中。
• CLASS OF NEAR INFRARED MOLECULAR PROBES FOR BIOLOGICAL APPLICATIONS
  申请人：Pang Yi

  公开号：US20140303376A1

  公开（公告）日：2014-10-09

  Methods for preparing 2,5-Bis(benzoxazol-2′-yl)benzene-1,4-diol derivatives (Zinhbo derivatives) are provided. Zinhbo derivatives are used to detect zinc ions and have particular application in vivo and in vitro. Zinhbo derivatives upon excitation give a florescence response emission that can be used to determine the presence of zinc cation in solution. Zinhbo derivatives complexed with zinc cations upon excitation can produce a florescence response emission in the visible and near infrared range. Zinhbo derivatives complexed with zinc cations exhibit a large stoke shift between the excitation and emission wavelengths.

  提供了制备2,5-双(苯并噁唑-2′-基)苯-1,4-二酚衍生物（Zinhbo衍生物）的方法。Zinhbo衍生物用于检测锌离子，在体内和体外具有特定应用。Zinhbo衍生物在激发后产生荧光响应发射，可用于确定溶液中锌阳离子的存在。Zinhbo衍生物与锌阳离子络合后在可见光和近红外范围内产生荧光响应发射。Zinhbo衍生物与锌阳离子络合后，在激发和发射波长之间表现出较大的斯托克位移。
• Synthesis of novel aromatic macrolactones via ring closing metathesis of substituted phenylalkanoic acid allylic esters
  作者：David P. Brown、Hoan Q. Duong

  DOI：10.1002/jhet.5570450222

  日期：2008.3

  Stable aromatic macrolactones have been synthesized and characterized from 2- and 3-substituted phenylalkanoic acid systems in modest yields.

  从2-和3-取代的苯基链烷酸体系以适度的产率合成并表征了稳定的芳族大内酯。